| Breakdown | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 |
|---|---|---|---|---|---|
Income Statement | |||||
| Total Revenue | 94.35M | 127.75M | 111.35M | 103.73M | 103.97M |
| Gross Profit | 38.49M | 62.23M | 46.81M | 37.69M | 33.95M |
| EBITDA | 15.00M | 46.60M | 31.54M | 19.10M | 33.97M |
| Net Income | 5.61M | 31.23M | 19.30M | 10.43M | 26.55M |
Balance Sheet | |||||
| Total Assets | 148.53M | 157.45M | 145.30M | 151.85M | 128.26M |
| Cash, Cash Equivalents and Short-Term Investments | 84.80M | 62.52M | 73.12M | 56.43M | 54.83M |
| Total Debt | 0.00 | 27.00K | 178.00K | 0.00 | 0.00 |
| Total Liabilities | 15.12M | 14.97M | 20.35M | 31.51M | 13.81M |
| Stockholders Equity | 132.35M | 141.34M | 124.23M | 119.88M | 114.26M |
Cash Flow | |||||
| Free Cash Flow | 36.86M | 2.11M | 30.79M | 7.82M | 22.09M |
| Operating Cash Flow | 40.23M | 6.46M | 34.24M | 23.95M | 32.63M |
| Investing Cash Flow | -3.34M | -2.50M | -3.05M | -17.55M | 1.42M |
| Financing Cash Flow | -14.43M | -14.56M | -14.53M | -4.80M | -14.25M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
72 Outperform | HK$522.19M | 3.43 | 27.72% | ― | 9.58% | 48.41% | |
69 Neutral | HK$1.03B | 9.81 | 35.42% | ― | 146.18% | 1617.05% | |
63 Neutral | HK$102.24M | 14.79 | -0.93% | 8.40% | -29.38% | -104.21% | |
61 Neutral | $37.18B | 12.37 | -10.20% | 1.83% | 8.50% | -7.62% | |
61 Neutral | HK$654.08M | 7.08 | 2.16% | 6.63% | -16.76% | -50.21% | |
54 Neutral | HK$1.28B | -3.52 | 1.98% | ― | -17.23% | -6.20% | |
40 Underperform | HK$65.54M | -1.62 | ― | ― | -43.10% | -5.98% |